Contact Information
Company Information
Company
Cognition Therapeutics, Inc.
Technologies
Mimecast
Outlook
Amazon SES
Nginx
Vimeo
WordPress.org
reCAPTCHA
New Relic
Google Tag Manager
Google Font API
Mobile Friendly
Remote
Keywords
neuroscience
drug development
clinical research
alzheimers disease
dementia with lewy bodies
dementia research
biotechnology
life sciences
biotechnology: biological products (no diagnostic substances)
health care
biotechnology research
neurodegenerative diseases
alzheimer's disease
lewy body dementia
cns disorders
oral medications
clinical trials
small-molecule therapies
therapeutic candidates
zervimesine
ct1812
sigma-2 receptor
cellular damage response
protein trafficking
neuronal protection
disease-modifying treatments
autophagy
cholesterol synthesis
pharmaceutical innovation
biopharmaceutical company
aging population
cell signaling
toxic protein buildup
oligomer antagonists
scientific publications
neurological conditions
patient advocacy
biomarker development
clinical operations
therapeutic portfolio
fda compliance
commercial manufacturing
therapeutics pipeline
phase 2 studies
investor relations
healthcare solutions
biotech industry
drug discovery
community engagement
medical research
pharmaceutical oversight
quality assurance
medical affairs
investigational drugs
research partnerships
clinical endpoints
patient enrollment
strategic development
health
wellness & fitness
hospital & health care
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans